Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Leukemia. 1997 Mar;11(3):315-27.

Application of myeloid growth factors in the treatment of acute myeloid leukemia.

Author information

  • 1Institute of Hematology, Erasmus University, Rotterdam, The Netherlands.


The current interest in the clinical use of the hematopoietic growth factors (HGF) in the treatment of patients with acute myeloid leukemia (AML) relates to the promise of reducing morbidity and improving survival through mitigating the complications of cytotoxic therapy. Another possible mode of employment of HGFs is derived from the ability of these peptides to directly stimulate leukemic cells and potentially enhance the efficacy of antileukemic therapy. Here we discuss the experimental basis and the rationale of the application of HGFs in AML and review the accumulating results from clinical studies.

Comment in

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk